Gustave Roussy — Villejuif

Public research footprint of Gustave Roussy, compiled from the ClinicalTrials.gov public registry.

1,869

Registered studies

687

Active

392

Recruiting now

816

Completed

245

Stopped or withdrawn

Most-studied conditions

Squamous Cell Carcinoma of Head and Neck · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Relapsed/Refractory Follicular Lymphoma · Leukemia, Myeloid, Acute

Recently updated registry entries

NCT07106632 — Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent… (Recruiting)
NCT06919965 — A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants… (Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Gustave Roussy?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.